SEC Filing · 424B3
BridgeBio Oncology Therapeutics, Inc.
BBOTNASDAQEQUITYCurrent
SEC Filing
Company context
Helix Acquisition Corp. II (Nasdaq: HLXB) is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Helix Acquisition Corp. II raised $184 million in its initial public offering on February 9, 2024. Helix is sponsored by affiliates of Cormorant Asset Management and is headquartered in Boston, Massachusetts.
Current securities
As-filed source
As filedOpen full document ↗